Literature DB >> 23096702

NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.

Elke Hacker1, Eduardo Nagore, Lorenzo Cerroni, Susan L Woods, Nicholas K Hayward, Brett Chapman, Grant W Montgomery, H Peter Soyer, David C Whiteman.   

Abstract

There is increasing epidemiologic and molecular evidence that cutaneous melanomas arise through multiple causal pathways. To further define the pathways to melanoma, we explored the relationship between germline and somatic mutations in a series of melanomas collected from 134 Spanish and 241 Austrian patients. Tumor samples were analyzed for melanocortin-1 receptor (MC1R) variants and mutations in the BRAF and NRAS genes. Detailed clinical data were systematically collected from patients. We found that NRAS-mutant melanomas were significantly more likely from older patients and BRAF-mutant melanomas were more frequent in melanomas from the trunk. We observed a nonsignificant association between germline MC1R status and somatic BRAF mutations in melanomas from trunk sites (odds ratio (OR) 1.8 (0.8-4.1), P=0.1), whereas we observed a significant inverse association between MC1R and BRAF for melanomas of the head and neck (OR 0.3 (0.1-0.8), P=0.02). This trend was observed in both the Spanish and Austrian populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23096702     DOI: 10.1038/jid.2012.385

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type.

Authors:  Elke Stadelmeyer; Ellen Heitzer; Margit Resel; Lorenzo Cerroni; Peter Wolf; Nadia Dandachi
Journal:  J Invest Dermatol       Date:  2013-08-09       Impact factor: 8.551

2.  Mutational analysis and clinical correlation of metastatic colorectal cancer.

Authors:  Andrea L Russo; Darrell R Borger; Jackie Szymonifka; David P Ryan; Jennifer Y Wo; Lawrence S Blaszkowsky; Eunice L Kwak; Jill N Allen; Raymond C Wadlow; Andrew X Zhu; Janet E Murphy; Jason E Faris; Dora Dias-Santagata; Kevin M Haigis; Leif W Ellisen; Anthony J Iafrate; Theodore S Hong
Journal:  Cancer       Date:  2014-02-05       Impact factor: 6.860

3.  Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Peter A Kanetsky; Klaus J Busam; Anne Kricker; Bruce K Armstrong; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Li Luo; Irene Orlow; Anne S Reiner; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; Eloise A Parrish; Honglin Hao; David C Gibbs; Jill S Frank; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2017-08-24       Impact factor: 8.551

4.  Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.

Authors:  Jennifer L Hay; Kate Zielaskowski; Kirsten Meyer White; Kimberly Kaphingst; Erika Robers; Dolores Guest; Andrew Sussman; Yvonne Talamantes; Matthew Schwartz; Vivian M Rodríguez; Yuelin Li; Elizabeth Schofield; Jessica Bigney; Keith Hunley; David Buller; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

5.  Endometriosis and the risk of skin cancer: a prospective cohort study.

Authors:  Leslie V Farland; Simon Lorrain; Stacey A Missmer; Laureen Dartois; Iris Cervenka; Isabelle Savoye; Sylvie Mesrine; Marie-Christine Boutron-Ruault; Marina Kvaskoff
Journal:  Cancer Causes Control       Date:  2017-08-10       Impact factor: 2.506

6.  Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype.

Authors:  M C Fargnoli; F Sera; M Suppa; D Piccolo; M T Landi; A Chiarugi; C Pellegrini; S Seidenari; K Peris
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-03-04       Impact factor: 6.166

7.  Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Authors:  Nancy E Thomas; Sharon N Edmiston; Irene Orlow; Peter A Kanetsky; Li Luo; David C Gibbs; Eloise A Parrish; Honglin Hao; Klaus J Busam; Bruce K Armstrong; Anne Kricker; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

Review 8.  The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

Authors:  Boris C Bastian
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

9.  Tumor homogeneity between primary and metastatic sites for BRAF status in metastatic melanoma determined by immunohistochemical and molecular testing.

Authors:  Lucile Boursault; Véronique Haddad; Béatrice Vergier; David Cappellen; Severine Verdon; Jean-Pierre Bellocq; Thomas Jouary; Jean-Philippe Merlio
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

Review 10.  Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention.

Authors:  Michele Manganelli; Stefania Guida; Anna Ferretta; Giovanni Pellacani; Letizia Porcelli; Amalia Azzariti; Gabriella Guida
Journal:  Genes (Basel)       Date:  2021-07-19       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.